Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up

Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.

External Link - article-128384.pdf

Articles in this issue

over 21 years ago

Article

A Novel Freeze Pelletization Technique for Preparing Matix Pellets

over 21 years ago

Article

Aseptic Processing: A Review of Current Industry Practice

over 21 years ago

Article

Can Inserts Be Improved?

over 21 years ago

Article

Analysis of a Kneading Process to Evaluate Drug Substance-Cyclodextrin Complexation

over 21 years ago

Article

Drug Development Linked More Closely to Diagnostics

over 21 years ago

Article

Preparation and In Vitro Characterization of Self-Nanoemulsified Drug Delivery Systems of Coenzyme Q10 Using Chiral Essential Oil Components

over 21 years ago

Article

In The Spotlight-October 2004

over 21 years ago

Article

October 2004

over 21 years ago

Article

Visible-Residue Limit for Cleaning Validation and its Potential Application in Pharmaceutical Research Facility

over 21 years ago

Article

The High Price of Success

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!